SEQUENT
vs
B
BSE Sensex 30
SEQUENT
Over the past 12 months, SEQUENT has significantly outperformed BSE Sensex 30, delivering a return of +29% compared to the BSE Sensex 30's +7% growth.
Stocks Performance
SEQUENT vs BSE Sensex 30
Performance Gap
SEQUENT vs BSE Sensex 30
Performance By Year
SEQUENT vs BSE Sensex 30
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
SeQuent Scientific Ltd
Glance View
SeQuent Scientific Ltd. manufactures and produces veterinary pharmaceuticals and specialty chemicals. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2016-03-10. The firm operates in the domains of animal health, in which it provides active pharmaceutical ingredient (APIs) and finished dosage formulations, and analytical services. The firm through its subsidiary, Alivira Animal Health Limited, offers APIs and formulations. Alivira Animal Health Limited has manufacturing facilities in five countries, including India. The Company’s subsidiary, Sequent Research Limited, is a contract research organization, which is engaged in analytical and biological analytical services to support the API, pharmaceutical, personal care and nutraceutical companies. Sequent Research Limited provides complete analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopeial monographs, customer-developed methods or in-house method development.
